1. Home
  2. INBS vs DSS Comparison

INBS vs DSS Comparison

Compare INBS & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

N/A

Current Price

$1.69

Market Cap

6.5M

Sector

Health Care

ML Signal

N/A

Logo DSS Inc.

DSS

DSS Inc.

N/A

Current Price

$0.52

Market Cap

7.0M

ML Signal

N/A

Company Overview

Basic Information
Metric
INBS
DSS
Founded
2016
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Containers/Packaging
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.0M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
INBS
DSS
Price
$1.69
$0.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 30.9K
25.1K
Earning Date
11-11-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 42.45
EPS
N/A
★ N/A
Revenue
$1,980,484.00
★ $2,085,000.00
Revenue This Year
$44.72
N/A
Revenue Next Year
$44.26
$43.35
P/E Ratio
★ N/A
N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.54
$0.36
52 Week High
$24.90
$1.86

Technical Indicators

Market Signals
Indicator
INBS
DSS
Relative Strength Index (RSI) 49.82 32.84
Support Level $1.52 $0.49
Resistance Level $1.92 $0.58
Average True Range (ATR) 0.10 0.03
MACD 0.04 -0.01
Stochastic Oscillator 80.95 13.07

Price Performance

Historical Comparison
INBS
DSS

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

Share on Social Networks: